Publications by authors named "Xuanjia Lin"

Claim this Profile
O
One day versus two days of hepatic arterial infusion with oxaliplatin and fluorouracil for patients with unresectable hepatocellular carcinoma.
Zhicheng Lai, Yexing Huang, Dongsheng Wen, Xuanjia Lin, Anna Kan

BMC Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive characterization of enhancer RNA in hepatocellular carcinoma reveals three immune subtypes with implications for immunotherapy.
Xiaoyun Bu, Shuang Liu, Dongsheng Wen, Anna Kan, Yujie Xu, Xuanjia Lin

Mol Ther Oncolytics· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma.
Xiaoyun Bu, Luyao Ma, Shuang Liu, Dongsheng Wen, Anna Kan, Xuanjia Lin

Cancer Cell Int· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis